Here’s a glimpse of the services that you may benefit from.
- Access to unique research models, such as Patient-derived xenografts and Polycystic kidney disease models
- IACUC and veterinary support
- Safety, tolerability and toxicology
- PK/PD studies
- Animal and supply management
- Dosing and animal handling
- Tissue and organ dissections
- Cryopreservation
- Necropsy
- Surgery
Additional support and guidance:
- Scientific support
- Analysis and interpretation of data
- Study preparation
- Access to our in vivo analysis systems
Curious about more information on our ISAP program?
Contact our expert Pascal for an outline of the program possibilities for your upcoming project.Want to read more?
Proven Compound Susceptible Tau[P301S] Mouse Model for Preclinical Proof of Concept
The Tau[P301S] mouse remains one of the most established in vivo models for evaluating therapeutics targeting tauopathies including Alzheimer's disease and frontotemporal dementia (FTD). Presented at AD/PD 2025 in Vienna, this poster provides comprehensive...
InnoSer Presents New Data at the 8th CKD Summit 2026: Advancing Preclinical Models for ADPKD Research
Next week, the kidney research community will gather in Boston for the 8th CKD Summit 2026, a premier event that brings together clinicians, researchers, and industry experts to discuss the latest advances in chronic kidney disease (CKD) research and therapy...
Home-Cage Behavior Discriminates Neurodegeneration Models from Healthy Aging Mice
Distinguishing pathological neurodegeneration from normal biological aging is a fundamental challenge in preclinical neuroscience. Presented at AD/PD 2023 in Gothenburg, this poster — developed in collaboration with Sylics and VU University Amsterdam — establishes a...


![Proven Compound Susceptible Tau[P301S] Mouse Model for Preclinical Proof of Concept](https://www.innoserlaboratories.com/wp-content/uploads/2026/03/Proven-Compound-susceptible-TauP301S-mouse-model-for-preclinical-proof-of-concept--400x250.png)

